E&C GOP Probes Whether Undue Influence Behind Variability Of FDA Foreign Inspections

By Jessica Karins / July 5, 2024 at 11:10 AM
Republican leaders on the House Energy & Commerce Committee want answers from FDA by Monday (July 8) on why there is so much variability in the agency’s foreign inspections, telling FDA in a recent letter they question the skill levels and integrity of the agency’s inspectorate and are probing whether some employees conducting oversight of Chinese and Indian facilities may have been unduly influenced or even accepted bribes, though they don’t provide evidence. The lawmakers wrote to FDA on June...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.